NCT04543071: Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma
- State
- Under way
- Phase
- Phase 2
- People
- 118 planned
- Started
- 9 Nov 2020
- Primary completion
- Jun 2028
- Arms
- Motixafortide, Cemiplimab, Gemcitabine, Nab-Paclitaxel
- Results
- None posted
- 9 Sep 2020: Trial registered
- 9 Nov 2020: Trial started